FibroBiologics Announces 1-20 Reverse Stock Split

Got story updates? Submit your updates here. ›

FibroBiologics Inc. (NASDAQ:FBLG) has announced that its shares will undergo a 1-20 reverse stock split before the market opens on Monday, March 30th. The reverse split was announced on March 25th and will adjust the number of shares owned by shareholders after the market close on Friday, March 27th.

Why it matters

Reverse stock splits are often used by companies to increase their share price and meet minimum listing requirements on major stock exchanges. This move by FibroBiologics suggests the company may be facing financial challenges and is looking to boost its stock price.

The details

FibroBiologics is a cell therapy and regenerative medicine company developing treatments for chronic diseases. The company's stock has traded between $0.19 and $1.53 over the past 12 months and closed at $0.22 per share on Thursday. With a market capitalization of just $14.87 million, the reverse split is likely an effort by FibroBiologics to maintain its NASDAQ listing.

• The 1-20 reverse stock split was announced on March 25, 2026.
• The reverse split will take effect before the market opens on March 30, 2026.
• The number of shares owned by shareholders will be adjusted after the market close on March 27, 2026.

What’s next

The reverse split is expected to take effect before the market opens on Monday, March 30th, at which point FibroBiologics' stock will begin trading at the adjusted price.